(Q44895082)

7 December 2017

Helicobacter pylori modulates cisplatin sensitivity in gastric cancer by down-regulating miR-141 expression. (English)

1 reference

7 December 2017

0 references

1 reference

Xiaoying Zhou

1

1 reference

7 December 2017

Jing Su

series ordinal

2

1 reference

7 December 2017

Li Zhu

series ordinal

3

1 reference

7 December 2017

Guoxin Zhang

series ordinal

4

1 reference

7 December 2017

17 March 2014

1 reference

7 December 2017

1 reference

7 December 2017

19

1 reference

7 December 2017

3

1 reference

7 December 2017

174-181

1 reference

Helicobacter pylori: gastric cancer and extragastric malignancies - clinical aspects

7 December 2017

1 reference

Exome sequencing identifies early gastric carcinoma as an early stage of advanced gastric cancer

21 January 2018

1 reference

Clinicopathological analysis of early-stage gastric cancers detected after successful eradication of Helicobacter pylori.

21 January 2018

1 reference

Treatment of Helicobacter pylori infection 2013.

21 January 2018

1 reference

Mutagenic potency of Helicobacter pylori in the gastric mucosa of mice is determined by sex and duration of infection

21 January 2018

1 reference

Interaction between dietary factors and Helicobacter pylori infection in noncardia gastric cancer: a population-based case-control study in China

21 January 2018

1 reference

Helicobacter pylori eradication on iatrogenic ulcer by endoscopic resection of gastric tumour: a prospective, randomized, placebo-controlled multi-centre trial

21 January 2018

1 reference

Helicobacter pylori infection predicts favorable outcome in patients with gastric cancer

21 January 2018

1 reference

Protective role of Helicobacter pylori infection in prognosis of gastric cancer: evidence from 2,454 patients with gastric cancer

21 January 2018

1 reference

MicroRNA microarray identifies Let-7i as a novel biomarker and therapeutic target in human epithelial ovarian cancer

21 January 2018

1 reference

miR-141 regulates KEAP1 and modulates cisplatin sensitivity in ovarian cancer cells

21 January 2018

1 reference

Levofloxacin-based and clarithromycin-based triple therapies as first-line and second-line treatments for Helicobacter pylori infection: a randomised comparative trial with crossover design.

21 January 2018

1 reference

Helicobacter pylori lipopolysaccharide: biological activities in vitro and in vivo, pathological correlation to human chronic gastritis and peptic ulcer

21 January 2018

1 reference

The risk factors for discrepancy after endoscopic submucosal dissection of gastric category 3 lesion (low grade dysplasia).

21 January 2018

1 reference

miR-34a regulates cisplatin-induce gastric cancer cell death by modulating PI3K/AKT/survivin pathway

21 January 2018

1 reference

P-glycoprotein mediates drug resistance via a novel mechanism involving lysosomal sequestration.

21 January 2018

1 reference

Reversal of multidrug resistance in gastric cancer cells by E2F-1 downregulation in vitro and in vivo

21 January 2018

1 reference

MicroRNA signatures in Helicobacter pylori-infected gastric mucosa.

21 January 2018

1 reference

A core microRNA signature associated with inducers of the epithelial-to-mesenchymal transition.

21 January 2018

1 reference

A new model for raf kinase inhibitory protein induced chemotherapeutic resistance

21 January 2018

1 reference

The emerging role of the Nrf2-Keap1 signaling pathway in cancer

21 January 2018

1 reference

MicroRNA-141 confers resistance to cisplatin-induced apoptosis by targeting YAP1 in human esophageal squamous cell carcinoma

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/HEL.12120

1 reference

7 December 2017

1 reference